Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

NASDAQ:PODD

Insulet Corporation

Last Close

244.98

08/11 21:00

Market Cap

13.84B

Beta: 0.79

Volume Today

1.55M

Avg: 903.28K

PE Ratio

112.49

PFCF: −1,079.98

People Not Available